The SGLT2 inhibitor empagliflozin promotes increased fatty acid oxidation in skeletal muscle cells. - Stevanovic S; Katare PB; Volledal HM; Bakke HG; Dolinar K; Pirkmajer S; Ouwens DM; Thoresen GH; Kase ET; Rustan AC (Naunyn-Schmiedeberg's archives of pharmacology, 2026)